Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with MS (Multiple Sclerosis), NMOSD, or anti-MOG disease for at least 2 years.
- People aged between 18 and 65 years old.
- People who speak English, as all study materials are only available in English.
Who may not be able to join:
- People who have a visual impairment (note: people with hearing impairments are not excluded, as the study video includes closed captions).
- People whose current mental health state is not considered suitable for palliative care discussions, based on the results of a standard questionnaire called the PHQ9. Those who score 11 or higher on this questionnaire — which may suggest major depression — would be referred for immediate support and would not be included in the study.
- People whose thinking or processing speed makes it difficult to take part in palliative care discussions, based on results from a cognitive test called the Processing Speed Test. A score below a certain threshold on this test may mean the trial site determines the person is not able to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6462262616
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Palliative care preferences (i.e., care considerations, discontinuation of care, versus continued full care) for neurological care (Aim 1).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.